Skip to main content

Bristol-Myers Squibb Company (BMY-N) Quote

Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 51.29
Day High 52.07
Open:51.95
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Bristol-Myer Sqb (BMY)
- Comtex SmarTrend(R) - Wed Oct 16, 1:19PM CDT
Comtex SmarTrend(R) - CMTX
Wed Oct 16, 1:19PM CDT
SmarTrend identified a Downtrend for Bristol-Myer Sqb (NYSE:BMY) on August 2nd, 2019 at $45.57. In approximately 3 months, Bristol-Myer Sqb has returned 13.93% as of today's recent price of $51.92.
PhRMA Appoints New Leadership to Board of Directors
- PR Newswire - Wed Oct 16, 1:00PM CDT
PR Newswire - CMTX
Wed Oct 16, 1:00PM CDT
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) appointed new leadership to its board of directors. David Ricks, chairman and CEO of Eli Lilly and Company, was named chairman-elect and Ramona Sequeira, President of Takeda Pharmaceuticals, USA assumed the role of board treasurer.
Coast 2 Coast 4 Cancer Riders Raise Nearly $730,000 to Help Achieve Victory Over Cancer(R)
- GlobeNewswire - Tue Oct 15, 8:00AM CDT
GlobeNewswire - CMTX
Tue Oct 15, 8:00AM CDT
The V Foundation for Cancer Research, a top-rated cancer research charity, is excited to announce that Bristol-Myers Squibb's 2019 Coast 2 Coast 4 Cancer riders raised a record-breaking $729,358 this year. Bristol-Myers Squibb matched all funds, for a total of nearly $1.5 million for cancer research funded through the V Foundation. More than 100 Bristol-Myers Squibb employees participated in the three-week, cross-country bike ride, beginning on September 4 and covering nearly 3,000 miles from Cannon Beach, Ore., to Long Branch, N.J.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 48.55 +6.10% increase
on 10/03/19
Period Open:49.47
Price movement based on the high, low and last over the given period.
52.14 -1.21% decrease
on 10/15/19
+2.04 (+4.12%) increase
since 09/16/19
3-Month 42.48 +21.26% increase
on 07/23/19
Period Open:44.45
Price movement based on the high, low and last over the given period.
52.14 -1.21% decrease
on 10/15/19
+7.06 (+15.88%) increase
since 07/16/19
52-Week 42.48 +21.26% increase
on 07/23/19
Period Open:57.83
Price movement based on the high, low and last over the given period.
59.28 -13.10% decrease
on 10/17/18
-6.32 (-10.93%) decrease
since 10/16/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).